NASDAQ:MMSI - Merit Medical Systems Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $77.60
  • Forecasted Upside: 34.23 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$57.81
▼ -0.63 (-1.08%)

This chart shows the closing price for MMSI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Merit Medical Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MMSI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MMSI

Analyst Price Target is $77.60
▲ +34.23% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Merit Medical Systems in the last 3 months. The average price target is $77.60, with a high forecast of $83.00 and a low forecast of $73.00. The average price target represents a 34.23% upside from the last price of $57.81.

This chart shows the closing price for MMSI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Merit Medical Systems. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 7 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/22/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/21/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/19/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/18/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/17/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/29/2021Wells Fargo & CompanyBoost Price TargetEqual Weight$68.00 ➝ $74.00Medium
9/30/2021Barrington ResearchInitiated CoverageBuy$79.00Medium
7/30/2021Barrington ResearchBoost Price TargetOutperform$71.00 ➝ $79.00High
7/30/2021Raymond JamesBoost Price TargetOutperform$69.00 ➝ $73.00High
7/30/2021Needham & Company LLCBoost Price TargetBuy$73.00 ➝ $83.00High
7/30/2021Wells Fargo & CompanyBoost Price TargetEqual Weight$65.00 ➝ $68.00High
7/30/2021Piper SandlerBoost Price TargetOverweight$73.00 ➝ $79.00High
4/30/2021Needham & Company LLCBoost Price TargetBuy$68.00 ➝ $73.00High
4/30/2021Barrington ResearchBoost Price TargetOutperform$63.00 ➝ $71.00Low
4/30/2021Raymond JamesBoost Price TargetOutperform$61.00 ➝ $69.00Low
3/3/2021Raymond JamesBoost Price TargetOutperform$60.00 ➝ $61.00Medium
2/25/2021Needham & Company LLCBoost Price TargetBuy$65.00 ➝ $68.00High
2/25/2021Raymond JamesReiterated RatingOutperform$60.00 ➝ $61.00High
2/25/2021Barrington ResearchBoost Price TargetOutperform$62.00 ➝ $63.00High
1/5/2021Needham & Company LLCUpgradeHold ➝ Buy$65.00N/A
11/11/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$51.00 ➝ $58.00Low
11/11/2020OppenheimerBoost Price TargetOutperform$55.00 ➝ $60.00Low
11/11/2020Raymond JamesBoost Price TargetOutperform$57.00 ➝ $60.00High
10/29/2020SidotiBoost Price TargetBuy$63.00 ➝ $72.00Medium
10/29/2020Barrington ResearchBoost Price TargetOutperform$54.00 ➝ $62.00High
10/29/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$42.00 ➝ $51.00High
10/29/2020OppenheimerBoost Price TargetOutperform$50.00 ➝ $55.00High
10/29/2020Raymond JamesBoost Price TargetPositive ➝ Outperform$51.00 ➝ $57.00High
10/29/2020Piper SandlerBoost Price TargetOverweight$55.00 ➝ $62.00High
9/28/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$42.00High
9/14/2020Raymond JamesReiterated RatingBuyLow
7/30/2020OppenheimerBoost Price TargetOutperform$46.00 ➝ $50.00Low
7/30/2020Raymond JamesBoost Price TargetOutperform$49.00 ➝ $51.00Low
7/30/2020Barrington ResearchBoost Price TargetOutperform$49.00 ➝ $54.00Low
7/30/2020Needham & Company LLCReiterated RatingHoldLow
7/30/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$50.00 ➝ $55.00Low
6/1/2020SidotiBoost Price TargetBuy$55.00 ➝ $63.00Medium
5/27/2020Barrington ResearchBoost Price TargetOutperform$42.00 ➝ $49.00Low
5/27/2020Raymond JamesBoost Price TargetOutperform$46.00 ➝ $49.00Low
4/24/2020Barrington ResearchUpgradeBuy$42.00Low
4/24/2020Raymond JamesBoost Price TargetOutperform$44.00 ➝ $46.00Low
4/24/2020Wells Fargo & CompanyBoost Price TargetUnderweight$33.00 ➝ $37.00High
4/24/2020OppenheimerReiterated RatingBuy$46.00High
4/20/2020Barrington ResearchUpgradeMarket Perform ➝ OutperformMedium
2/26/2020Needham & Company LLCReiterated RatingHoldHigh
2/25/2020Piper SandlerReiterated RatingOverweight$42.00 ➝ $50.00High
2/25/2020Barrington ResearchDowngradeOutperform ➝ Market PerformHigh
2/25/2020Wells Fargo & CompanyBoost Price TargetUnderweight$26.00 ➝ $33.00High
2/25/2020Raymond JamesBoost Price TargetOutperform$43.00 ➝ $47.00High
2/7/2020OppenheimerBoost Price Target$32.00 ➝ $43.00Low
2/3/2020Raymond JamesUpgradeMarket Perform ➝ Outperform$43.00Medium
1/14/2020Piper SandlerBoost Price Target$30.00 ➝ $42.00Medium
12/12/2019Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$26.00High
10/31/2019Barrington ResearchLower Price TargetOutperform$59.00 ➝ $31.00High
10/31/2019Needham & Company LLCReiterated RatingHoldHigh
10/31/2019Piper Jaffray CompaniesLower Price TargetOverweight$40.00 ➝ $30.00High
9/23/2019OppenheimerInitiated CoverageOutperform$40.00Low
9/17/2019Piper Jaffray CompaniesLower Price TargetOverweight$58.00 ➝ $40.00High
9/13/2019Bank of AmericaSet Price TargetHold$37.00Medium
9/12/2019Barrington ResearchInitiated CoverageBuy$59.00Low
9/10/2019Raymond JamesDowngradeOutperform ➝ Market PerformHigh
7/26/2019SidotiSet Price TargetBuy$74.00N/A
7/26/2019Barrington ResearchReiterated RatingBuy$59.00High
7/26/2019Needham & Company LLCDowngradeBuy ➝ HoldHigh
7/26/2019Wells Fargo & CompanyDowngradeOutperform ➝ Market Perform$71.00 ➝ $46.00High
7/26/2019Piper Jaffray CompaniesSet Price TargetOverweight$75.00 ➝ $58.00High
4/25/2019Needham & Company LLCReiterated RatingBuyHigh
12/17/2018Needham & Company LLCReiterated RatingBuy$73.00High
10/2/2018SidotiSet Price TargetBuy$79.00Low
10/2/2018Piper Jaffray CompaniesBoost Price TargetOverweight$58.00 ➝ $72.00Low
10/2/2018Barrington ResearchBoost Price TargetOutperform$69.00Low
10/2/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$67.00 ➝ $73.00High
8/27/2018SunTrust BanksBoost Price TargetBuy$68.00Low
8/7/2018Bank of AmericaDowngradeBuy ➝ Underperform$64.00High
7/24/2018Barrington ResearchBoost Price TargetOutperform$50.00 ➝ $61.00High
7/24/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$59.00 ➝ $61.00Low
7/24/2018Needham & Company LLCBoost Price TargetBuy$54.00 ➝ $67.00High
6/4/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$53.00 ➝ $58.00Medium
6/1/2018Needham & Company LLCReiterated RatingBuy$54.00Low
6/1/2018SunTrust BanksReiterated RatingBuy$55.00 ➝ $62.00Low
5/18/2018SunTrust BanksBoost Price TargetBuy$55.00 ➝ $62.00Low
4/26/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$50.00 ➝ $51.00High
4/26/2018Needham & Company LLCBoost Price TargetBuy ➝ Buy$53.00 ➝ $54.00High
4/20/2018Needham & Company LLCInitiated CoverageBuy$53.00 ➝ $53.00Low
3/7/2018SunTrust BanksBoost Price TargetBuy$1.64 ➝ $55.00Low
3/1/2018Barrington ResearchUpgradeMarket Perform ➝ Outperform$50.00High
11/30/2017Wells Fargo & CompanyReiterated RatingOutperform$46.00 ➝ $51.00Medium
11/16/2017SunTrust BanksSet Price TargetBuy$47.00N/A
8/28/2017Raymond JamesReiterated RatingStrong-Buy ➝ Outperform$44.00Low
8/28/2017CitigroupDowngradeStrong-Buy ➝ Outperform$44.00Low
8/28/2017UBS GroupDowngradeStrong-Buy ➝ OutperformLow
7/28/2017Piper Jaffray CompaniesReiterated RatingBuy$45.00Low
7/27/2017Craig HallumReiterated RatingBuy$42.00 ➝ $50.00High
7/20/2017Bank of AmericaInitiated CoverageBuy ➝ Buy$44.00Medium
6/28/2017SidotiReiterated RatingBuy$41.00 ➝ $46.00Low
6/26/2017Piper Jaffray CompaniesReiterated RatingOverweight$39.00Low
6/20/2017SunTrust BanksInitiated CoverageBuy ➝ Buy$43.00High
4/29/2017SidotiReiterated RatingBuy$35.00 ➝ $41.00Low
4/17/2017Craig HallumInitiated CoverageBuy$36.00High
4/6/2017Keefe, Bruyette & WoodsReiterated RatingHold$20.00Low
4/5/2017Wells Fargo & CompanyInitiated CoverageOutperform$17.94 ➝ $31.70Low
3/29/2017Piper Jaffray CompaniesReiterated RatingOverweight ➝ OverweightLow
(Data available from 1/17/2017 forward)

News Sentiment Rating

1.24 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/21/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/21/2021
  • 9 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/20/2021
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/19/2021
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2021
  • 5 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/18/2021
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/18/2021
  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/17/2022

Current Sentiment

  • 3 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Merit Medical Systems logo
Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
Read More

Today's Range

Now: $57.81
Low: $57.02
High: $58.38

50 Day Range

MA: $63.86
Low: $57.81
High: $69.27

52 Week Range

Now: $57.81
Low: $52.43
High: $73.85

Volume

158,157 shs

Average Volume

203,260 shs

Market Capitalization

$3.26 billion

P/E Ratio

76.07

Dividend Yield

N/A

Beta

1.12

Frequently Asked Questions

What sell-side analysts currently cover shares of Merit Medical Systems?

The following Wall Street sell-side analysts have issued research reports on Merit Medical Systems in the last year: Barrington Research, Needham & Company LLC, Piper Sandler, Raymond James, and Wells Fargo & Company.
View the latest analyst ratings for MMSI.

What is the current price target for Merit Medical Systems?

5 Wall Street analysts have set twelve-month price targets for Merit Medical Systems in the last year. Their average twelve-month price target is $77.60, suggesting a possible upside of 34.2%. Needham & Company LLC has the highest price target set, predicting MMSI will reach $83.00 in the next twelve months. Raymond James has the lowest price target set, forecasting a price of $73.00 for Merit Medical Systems in the next year.
View the latest price targets for MMSI.

What is the current consensus analyst rating for Merit Medical Systems?

Merit Medical Systems currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MMSI will outperform the market and that investors should add to their positions of Merit Medical Systems.
View the latest ratings for MMSI.

What other companies compete with Merit Medical Systems?

How do I contact Merit Medical Systems' investor relations team?

Merit Medical Systems' physical mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The medical instruments supplier's listed phone number is (801) 253-1600 and its investor relations email address is [email protected] The official website for Merit Medical Systems is www.merit.com.